trial

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)

NCTId NCT06961916
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 120 (estimated)
Sponsored by The University of Texas Health Science Center, Houston
Primary completion 2029-05-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2025-06-03
Primary completion
2029-05-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Active rTMSCognitive training

Sponsors

The University of Texas Health Science Center, HoustonLead Sponsor

Investigators

1
Xiaoming Du, PhDPrincipal Investigator

Sites

1 total
Houston, United States

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2029-05-01
Status
RECRUITING
relationships
The graph out of here
drug
Active rTMS
drug
Cognitive training
drug
lead_sponsor
The University of Texas Health Science Center, Houston
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Xiaoming Du, PhD
person